发明公开
- 专利标题： POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS
- 专利标题（中）： 丙型肝炎病毒的强效和选择性抑制剂
-
申请号： EP11820753申请日： 2011-08-26
-
公开(公告)号： EP2616461A4公开(公告)日： 2014-03-26
- 发明人: COATS STEVEN J , AMBLARD FRANCK , ZHANG HONGWANG , ZHOU LONGHU , WHITAKER RICHARD ANTHONY , MCBRAYER TAMARA ROSARIO , SCHINAZI RAYMOND F , SHI JUNXING
- 申请人： RFS PHARMA LLC , UNIV EMORY
- 专利权人： RFS PHARMA LLC,UNIV EMORY
- 当前专利权人： RFS PHARMA LLC,UNIV EMORY
- 优先权： US201161494877 2011-06-08; US37745210 2010-08-26
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; A61K31/4178 ; A61P31/14 ; C07D403/14 ; C07D405/14 ; C07D413/14
摘要：
The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment or prevention of HCV infection.
信息查询
